Given the strong correlation between serum LDH levels and total IgE, blood eosinophil counts and disease severity [4,5,20,21], it could be possible that the AD subgroups defined in the present study may not be specific to serum LDH levels, and that adjustment for any of those clinical parameters would provide similar outcomes. This evidence concerns the gene IGHE and Alzheimer disease.